ELIQUIS 2.5 mg/1 (Apixaban TABLET, FILM COATED) 2.5 mg/1

ELIQUIS 2.5 mg is an oral medication used to reduce the risk of blood clots. This film-coated tablet contains apixaban, a common anticoagulant. Learn more about ELIQUIS and its uses.

Strength

2.5 mg/1

Pack Size

10 BLISTER PACK in 1 CARTON (0003-0893-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ELIQUIS 2.5 mg is primarily used to prevent blood clots in conditions like atrial fibrillation. It is also used to treat deep vein thrombosis and pulmonary embolism. People often ask, 'What is ELIQUIS used for?' This medication helps manage conditions where blood clots pose a risk.

Side Effects

Common effects of ELIQUIS 2.5 mg may include bruising, bleeding, and nausea. Some users report dizziness or fatigue. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle ELIQUIS 2.5 mg with care, especially if you have bleeding disorders or are undergoing surgery. Store the medication as directed and keep it out of reach of children. Follow your healthcare provider's instructions for safe use.

Avoid Interactions

ELIQUIS 2.5 mg may interact with other medications, including blood thinners and certain antibiotics. Alcohol can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ELIQUIS is used to reduce the risk of blood clots in conditions like atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism.

Store ELIQUIS at room temperature, away from moisture and heat. Keep it in its original packaging until ready to use.

ELIQUIS may interact with other medications, so always consult your healthcare provider before combining it with other drugs.

Common side effects include bruising, bleeding, nausea, dizziness, and fatigue. Not everyone experiences these effects.

ELIQUIS may not be suitable for everyone, especially those with bleeding disorders or upcoming surgeries. Always consult a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.